• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯丁酸盐可诱导人前列腺癌细胞凋亡,且其作用比苯乙酸更强。

Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate.

作者信息

Carducci M A, Nelson J B, Chan-Tack K M, Ayyagari S R, Sweatt W H, Campbell P A, Nelson W G, Simons J W

机构信息

The Johns Hopkins Oncology Center and The Brady Urological Institute, Baltimore, Maryland 21205, USA.

出版信息

Clin Cancer Res. 1996 Feb;2(2):379-87.

PMID:9816181
Abstract

Phenylbutyrate (PB), a novel lead compound for prostate cancer therapy, has molecular activities distinct from its metabolite, phenylacetate (PA). Both PB and PA promote differentiation in human prostate cancer cell lines, yet little data exist comparing the cytotoxic effects of each drug. We found that PB is more potent than PA in vitro; PB is 1.5-2.5 times more active at inhibiting growth and inducing programmed cell death than PA at clinically achievable doses against each human prostate cancer line studied. PB is equipotent to sodium butyrate, which induces apoptosis and differentiation through multiple mechanisms. Exposure of prostate cancer cell lines to PB reduces their DNA synthesis, leads to fragmentation of genomic DNA, and causes 50-60% of cells to undergo apoptosis. These PB-induced effects are 2-10 times greater than those of the control or PA. The stereotypical changes of apoptosis can be seen with sodium butyrate at similar concentrations, but not with PA. Prostate cancer cell lines overexpressing P-glycoprotein or possessing heterogeneous molecular alterations, including p53 mutations, are also sensitive to the effects of PB. In vivo, Copenhagen rats treated with oral PB had delayed growth of the androgen refractory Dunning R-3327 MAT-LyLu prostate cancer subline by 30-45% in a dose-dependent manner. These results demonstrate that PB induces cytotoxicity via apoptosis in human prostate cancer, in addition to its differentiating properties.

摘要

苯丁酸盐(PB)是一种用于前列腺癌治疗的新型先导化合物,具有与其代谢产物苯乙酸盐(PA)不同的分子活性。PB和PA均可促进人前列腺癌细胞系的分化,但比较每种药物细胞毒性作用的数据很少。我们发现,PB在体外比PA更具效力;在针对所研究的每个人前列腺癌系的临床可达到剂量下,PB在抑制生长和诱导程序性细胞死亡方面的活性比PA高1.5至2.5倍。PB与丁酸钠等效,丁酸钠可通过多种机制诱导细胞凋亡和分化。前列腺癌细胞系暴露于PB会降低其DNA合成,导致基因组DNA片段化,并使50%至60%的细胞发生凋亡。这些PB诱导的效应比对照或PA的效应大2至10倍。在相似浓度下,丁酸钠可观察到典型的凋亡变化,但PA则不会。过表达P-糖蛋白或具有包括p53突变在内的异质性分子改变的前列腺癌细胞系,对PB的作用也敏感。在体内,口服PB治疗的哥本哈根大鼠,其雄激素抵抗性Dunning R-3327 MAT-LyLu前列腺癌亚系的生长以剂量依赖性方式延迟了30%至45%。这些结果表明,PB除具有分化特性外,还可通过诱导人前列腺癌细胞凋亡发挥细胞毒性作用。

相似文献

1
Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetate.苯丁酸盐可诱导人前列腺癌细胞凋亡,且其作用比苯乙酸更强。
Clin Cancer Res. 1996 Feb;2(2):379-87.
2
Impact of the putative differentiating agents sodium phenylbutyrate and sodium phenylacetate on proliferation, differentiation, and apoptosis of primary neoplastic myeloid cells.
Clin Cancer Res. 1997 Oct;3(10):1755-62.
3
Vulnerability of multidrug-resistant tumor cells to the aromatic fatty acids phenylacetate and phenylbutyrate.多药耐药肿瘤细胞对芳香族脂肪酸苯乙酸和苯丁酸盐的敏感性
Clin Cancer Res. 1996 May;2(5):865-72.
4
Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells.苯丁酸盐和苯乙酸盐可诱导人髓母细胞瘤细胞分化并抑制其增殖。
Clin Cancer Res. 2004 Feb 1;10(3):1150-9. doi: 10.1158/1078-0432.ccr-0747-3.
5
Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivo.
Int J Oncol. 1999 Mar;14(3):501-8. doi: 10.3892/ijo.14.3.501.
6
Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents.苯丁酸盐或苯乙酸盐与化疗药物联合诱导恶性B细胞凋亡
Clin Cancer Res. 2000 Feb;6(2):681-92.
7
Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.分化剂与细胞周期依赖性细胞毒性药物联合使用时的序列依赖性抗肿瘤作用。
Cancer Chemother Pharmacol. 2007 Aug;60(3):329-39. doi: 10.1007/s00280-006-0379-2. Epub 2007 Jan 26.
8
Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis.苯丁酸盐与13-顺式维甲酸联合使用可抑制前列腺肿瘤生长和血管生成。
Cancer Res. 2001 Feb 15;61(4):1477-85.
9
Increases in NMR-visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells.在苯丁酸钠诱导人前列腺癌细胞凋亡过程中,核磁共振可见脂质和甘油磷酸胆碱增加。
Biochim Biophys Acta. 2005 May 1;1734(1):1-12. doi: 10.1016/j.bbalip.2005.01.008. Epub 2005 Feb 24.
10
A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion schedule.苯丁酸钠按120小时输注方案进行的I期临床和药理学评估。
Clin Cancer Res. 2001 Oct;7(10):3047-55.

引用本文的文献

1
Advancing prostate cancer treatment: the role of fecal microbiota transplantation as an adjuvant therapy.推进前列腺癌治疗:粪便微生物群移植作为辅助治疗的作用。
Curr Res Microb Sci. 2025 Jun 11;9:100420. doi: 10.1016/j.crmicr.2025.100420. eCollection 2025.
2
Molecular pathogenesis, mechanism and therapy of Cav1 in prostate cancer.Cav1在前列腺癌中的分子发病机制、作用机制及治疗
Discov Oncol. 2023 Nov 1;14(1):196. doi: 10.1007/s12672-023-00813-0.
3
Dissecting Microbiome-Derived SCFAs in Prostate Cancer: Analyzing Gut Microbiota, Racial Disparities, and Epigenetic Mechanisms.
剖析前列腺癌中微生物群衍生的短链脂肪酸:分析肠道微生物群、种族差异和表观遗传机制。
Cancers (Basel). 2023 Aug 14;15(16):4086. doi: 10.3390/cancers15164086.
4
Targeting Glutamine Metabolism in Prostate Cancer.靶向前列腺癌中的谷氨酰胺代谢。
Front Biosci (Elite Ed). 2023 Jan 4;15(1):2. doi: 10.31083/j.fbe1501002.
5
Influence of the Fatty Acid Metabolism on the Mode of Action of a Cisplatin(IV) Complex with Phenylbutyrate as Axial Ligands.脂肪酸代谢对以苯丁酸盐为轴向配体的顺铂(IV)配合物作用模式的影响。
Pharmaceutics. 2023 Feb 16;15(2):677. doi: 10.3390/pharmaceutics15020677.
6
Role of microbiome and its metabolite, short chain fatty acid in prostate cancer.微生物组及其代谢产物短链脂肪酸在前列腺癌中的作用。
Investig Clin Urol. 2023 Jan;64(1):3-12. doi: 10.4111/icu.20220370.
7
Phenylbutyrate modulates polyamine acetylase and ameliorates Snyder-Robinson syndrome in a Drosophila model and patient cells.苯丁酸钠调节多胺乙酰基转移酶,改善果蝇模型和患者细胞中的 Snyder-Robinson 综合征。
JCI Insight. 2022 Jul 8;7(13):e158457. doi: 10.1172/jci.insight.158457.
8
Pharmacological targeting of endoplasmic reticulum stress in disease.内质网应激在疾病中的药理学靶向治疗。
Nat Rev Drug Discov. 2022 Feb;21(2):115-140. doi: 10.1038/s41573-021-00320-3. Epub 2021 Oct 26.
9
Therapeutic Approaches Targeting Proteostasis in Kidney Disease and Fibrosis.治疗肾脏病和纤维化的靶向蛋白稳态策略。
Int J Mol Sci. 2021 Aug 12;22(16):8674. doi: 10.3390/ijms22168674.
10
Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy.增强谷氨酰胺代谢抑制剂在癌症治疗中的疗效。
Trends Cancer. 2021 Aug;7(8):790-804. doi: 10.1016/j.trecan.2021.04.003. Epub 2021 May 18.